Bio/Pharma/CRO Archives - Page 2 of 49 - Scientific Technology News

June 30, 2023 Bio/Pharma/CRO Informatics & Software Lab Top-10

Bruker Announces SciY™ Platform of Advanced Scientific and Automation Software Solutions for the Digital Transformation of the Life Science and Biopharma Industries

ZUERICH, Switzerland–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the SciY™ platform of advanced, vendor-agnostic software solutions for data analysis, data management, research lab and bioproduction QC digitalization, and workflow automation in the life science industry and for biopharma companies. The new SciY platform combines and integrates high-performance lab software solutions for a more comprehensive,... Read more

February 10, 2023 Bio/Pharma/CRO Product Launch

New phase III data show Roche’s Vabysmo rapidly improved vision and reduced retinal fluid in people with retinal vein occlusion (RVO)

February 7, 2023 Bio/Pharma/CRO

Roche announces positive data from global phase III programme for crovalimab in PNH, a rare life-threatening blood condition

January 19, 2023 Bio/Pharma/CRO

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s Tecentriq plus Avastin is the first treatment combination to reduce the risk of cancer returning in people with certain types of early-stage liver cancer in a Phase III trial

January 4, 2023 Bio/Pharma/CRO Lab Top-10 Licensing, IP, and Legal Liq. Handling & Robotics M&A, Partnerships Other Lab Products/Services

Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys’ leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics research, disease biomarker discovery, drug discovery and development, and clinical trials leveraging pharmacoproteomics With Bruker investments, Biognosys plans to open advanced US proteomics CRO facility for proteomics biomarker and drug... Read more

November 18, 2022 Bio/Pharma/CRO Chemicals, Reagents & Kits Clinical Research/Diagn.

Making Nissui Pharmaceutical as a Wholly-Owned SubsidiaryExpanding the Clinical Testing Business Based on Synergies between Analytical and Measuring Instruments and Culture Media/Reagents

Making Nissui Pharmaceutical as a Wholly-Owned SubsidiaryExpanding the Clinical Testing Business Based on Synergies between Analytical and Measuring Instruments and Culture Media/Reagents Read more

November 18, 2022 Bio/Pharma/CRO Chemicals, Reagents & Kits Clinical Research/Diagn.

Making Nissui Pharmaceutical as a Wholly-Owned SubsidiaryExpanding the Clinical Testing Business Based on Synergies between Analytical and Measuring Instruments and Culture Media/Reagents

November 14, 2022 Bio/Pharma/CRO

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s disease

October 27, 2022 Bio/Pharma/CRO

Positive topline phase III results show Roche's Vabysmo improved vision for people living with retinal vein occlusion (RVO)

October 13, 2022 Bio/Pharma/CRO M&A, Partnerships

Cytel to acquire SDS Life Science and SDS MedteQ to enhance and expand thought-leadership in strategic therapeutic development

Waltham, MA, October 13, 2022 – Cytel Inc., provider of quantitative insights and health data analytics to leaders in life sciences, has entered into an agreement to acquire SDS Life Science AB and SDS MedteQ AB. The move will add new global talent to Cytel’s Strategic Consulting group and bring additional expertise and capabilities for the... Read more